17 research outputs found
Comparison of Topical Nifedipine With Oral Nifedipine for Treatment of Anal Fissure: A Randomized Controlled Trial
Incidence rate of ovarian cancer in Iran in comparison with developed countries
Background: Ovarian cancer is one of the most common gynecologic
malignancies. The present study was designed to compare
age-standardized incidence rate (ASR) of ovarian cancer in Iran with
that in Australia and some other developed countries. Materials and
Methods: Data from the Cancer Registry Program of Iran, as a base,
were compared with the cancer registry reports of surveillance,
epidemiology and end results program in the USA, considering the
population of the USA in the year 2000 as the standard population.
Results: In all the age groups, ASR of ovarian cancer was much lower in
Iran. Overall rates of ovarian cancer in Iran and the USA were 3.9 and
16.2 per 100,000, respectively. Conclusion: Age-standardized ovarian
cancer rate in Iran was much lower in comparison with high incidence
areas in the world. Encouraging oral contraceptive use and reduction in
fat intake may be effective in decreasing the rate of ovarian cancer or
keeping its rate constant in Iran
Incidence rate of ovarian cancer in Iran in comparison with developed countries
Background: Ovarian cancer is one of the most common gynecologic
malignancies. The present study was designed to compare
age-standardized incidence rate (ASR) of ovarian cancer in Iran with
that in Australia and some other developed countries. Materials and
Methods: Data from the Cancer Registry Program of Iran, as a base,
were compared with the cancer registry reports of surveillance,
epidemiology and end results program in the USA, considering the
population of the USA in the year 2000 as the standard population.
Results: In all the age groups, ASR of ovarian cancer was much lower in
Iran. Overall rates of ovarian cancer in Iran and the USA were 3.9 and
16.2 per 100,000, respectively. Conclusion: Age-standardized ovarian
cancer rate in Iran was much lower in comparison with high incidence
areas in the world. Encouraging oral contraceptive use and reduction in
fat intake may be effective in decreasing the rate of ovarian cancer or
keeping its rate constant in Iran
Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains
Raynaud’s Phenomenon is a vascular affliction resulting in pain and blanching of the skin caused by excessive and prolonged constriction of arterioles, usually due to cold exposure. Nifedipine is a vasodilatory calcium channel antagonist, which is used orally as the first-line pharmacological treatment to reduce the incidence and severity of attacks when other interventions fail to alleviate the condition and there is danger of tissue injury. Oral administration of nifedipine, however, is associated with systemic adverse effects, and thus topical administration with nifedipine locally to the extremities would be advantageous. However, nifedipine is subject to rapid photodegradation, which is problematic for exposed skin such as the hands. The goal of this project was to analyze the photostability of a novel topical nifedipine cream to UVA light. The effect of incorporating the photoprotectants rutin, quercetin, and/or avobenzone (BMDBM) into the nifedipine cream on the stability of nifedipine to UVA light exposure and the appearance of degradation products of nifedipine was determined. Rutin and quercetin are flavonoids with antioxidant activity. Both have the potential to improve the photostability of nifedipine by a number of mechanisms that either quench the intermolecular electron transfer of the singlet excited dihydropyridine to the nitrobenzene group or by preventing photoexcitation of nifedipine. Rutin at either 0.1% or 0.5% (w/w) did not improve the stability of nifedipine 2% (w/w) in the cream after UVA exposure up to 3 h. Incorporation of quercetin at 0.5% (w/w) did improve nifedipine stability from 40% (no quercetin) to 77% (with quercetin) of original drug concentration after 3 h UVA exposure. A combination of BMDBM and quercetin was the most effective photoprotectant for maintaining nifedipine concentration following up to 8 h UVA exposure.Pharmaceutical Sciences, Faculty ofNon UBCReviewedFacult
Effectiveness of brief interventions as part of the screening, brief intervention and referral to treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: a systematic review protocol
Abstract
Background
There is a significant public health burden associated with substance use in Canada. The early detection and/or treatment of risky substance use has the potential to dramatically improve outcomes for those who experience harms from the non-medical use of psychoactive substances, particularly adolescents whose brains are still undergoing development. The Screening, Brief Intervention, and Referral to Treatment model is a comprehensive, integrated approach for the delivery of early intervention and treatment services for individuals experiencing substance use-related harms, as well as those who are at risk of experiencing such harm.
Methods
This article describes the protocol for a systematic review of the effectiveness of brief interventions as part of the Screening, Brief Intervention, and Referral to Treatment model for reducing the non-medical use of psychoactive substances. Studies will be selected in which brief interventions target non-medical psychoactive substance use (excluding alcohol, nicotine, or caffeine) among those 12 years and older who are opportunistically screened and deemed at risk of harms related to psychoactive substance use. We will include one-on-one verbal interventions and exclude non-verbal brief interventions (for example, the provision of information such as a pamphlet or online interventions) and group interventions. Primary, secondary and adverse outcomes of interest are prespecified. Randomized controlled trials will be included; non-randomized controlled trials, controlled before-after studies and interrupted time series designs will be considered in the absence of randomized controlled trials. We will search several bibliographic databases (for example, MEDLINE, EMBASE, CINAHL, PsycINFO, CORK) and search sources for grey literature. We will meta-analyze studies where possible. We will conduct subgroup analyses, if possible, according to drug class and intervention setting.
Discussion
This review will provide evidence on the effectiveness of brief interventions as part of the Screening, Brief Intervention, and Referral to Treatment protocol aimed at the non-medical use of psychoactive substances and may provide guidance as to where future research might be most beneficial